In this article, we will examine the 15 Best Multibagger Stocks to Invest in Right Now.

Just as a single diamond can outshine a handful of pebbles, a well-chosen multibagger can transform an ordinary portfolio into an extraordinary one. By definition, multibagger stocks are companies that deliver returns far exceeding the broader market, often doubling, tripling, or multiplying their value many times over.

The term was popularized by legendary fund manager Peter Lynch, who coined expressions like “tenbagger” to describe stocks that appreciate tenfold. Lynch believed that investors could spot good companies by observing their daily lives, at the mall, in restaurants, or at work. He argued that this kind of awareness often gave individual investors an advantage over Wall Street, which usually recognized these trends only after the fact.

READ ALSO:  12 Overlooked Large-Cap Stocks with Low Multiples and 10 Best Stocks for a 20 Year Long-Term Stock Portfolio.

The essence of finding multibaggers lies in spotting companies with sustainable growth drivers, strong competitive positions, and the ability to scale. These are businesses that tap into long-term trends, be it technology adoption, consumer demand shifts, or new industrial cycles, and convert that momentum into consistent earnings growth.

The market is already ripe for further gains, with expectations running high on an upcoming rate cut. In a recent CNBC interview, Gabriela Santos, Americas Chief Market Strategist at JPMorgan Asset Management, stated that U.S. equities are expected to continue setting new highs through the rest of the year. While many analysts and investors, including Ed Yardeni of Yardeni Research, have set targets of 6,600 for the S&P 500, Mary Ann Bartels, Chief Investment Strategist at Sanctuary Wealth, believes the index could reach 7,000 by year’s end.

In these scenarios, finding the next multibagger is never easy, but the payoff can be significant. One winning stock can offset several laggards, making multibaggers a valuable part of any long-term portfolio.

With those insights in mind, let’s now explore the 15 best multibagger stocks to invest in right now.

Our Methodology

To compile our list of the best multibagger stocks, we first screened U.S.-listed companies with a market capitalization above $500 million. From this group, we shortlisted stocks that had delivered at least 100% returns over the past year and offered a further potential upside of 40% or more. We then ranked the top 15 stocks in ascending order of their estimated upside. Additionally, we also included data on hedge fund holdings in these companies as of Q2 2025 from Insider Monkey’s database to provide further insight into investor interest.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Note: All pricing data is as of market close on September 4, 2025.

15 Best Multibagger Stocks to Invest in Right Now

15. Scholar Rock Holding Corp. (NASDAQ:SRRK)

Market Cap: $3.1 Billion

Price Return over 1-Year: 270%

Potential Upside: 57%

Number of Hedge Fund Holders: 44

Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of the best multibagger stocks to invest in right now. The company’s stock’s performance was largely supported by optimism around its lead drug candidate, apitegromab. The stock surged nearly sixfold in 2024, but as the company approaches a potential U.S. market launch in Q3 2025, volatility has increased. Shares are down approximately 25% year-to-date, although market sentiment remains highly positive, with a consensus Buy rating.

Why is apitegromab viewed as a potential game changer? Scholar Rock Holding Corp. (NASDAQ:SRRK) highlights that it is the first and only muscle-targeted therapy to show clinically meaningful and statistically significant functional improvement in SMA, and the only anti-myostatin therapy to demonstrate such results in a pivotal Phase 3 trial. Scholar Rock Holding Corp. (NASDAQ:SRRK) estimates the global market opportunity for apitegromab in SMA could exceed $2 billion, highlighting its strong commercial potential.

Recent analyst commentary suggests that bullish expectations for Scholar Rock Holding Corp. (NASDAQ:SRRK) are likely to continue. On August 21, Jefferies analyst Amy Li initiated coverage on the stock with a Buy rating and a $50 price target. Li views apitegromab, the company’s lead drug candidate, as a strong commercial opportunity in spinal muscular atrophy (SMA), arguing that an FDA approval covering patients aged two and older across SMA types 1-4 would substantially expand the drug’s addressable market.

The analyst noted that the September 22 PDUFA date could face a modest delay into the first quarter due to procedural issues flagged during an FDA site inspection. However, she does not believe this will affect the likelihood of approval. Li modeled risk-adjusted peak sales of $1.8 billion for apitegromab, with a 90% probability of success in patients over two years of age and 50% for those under two.

She also highlighted the longer-term potential for apitegromab and pipeline candidate SRK-439 in other neuromuscular conditions, including Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD), as well as possible applications in obesity through external partnerships.

Scholar Rock Holding Corp. (NASDAQ:SRRK) is a late-stage biopharmaceutical company focused on developing therapies for spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases.

14. Archer Aviation Inc. (NYSE:ACHR)

Market Cap: $5.3 Billion

Price Return over 1-Year: 152%

Potential Upside: 59%

Number of Hedge Fund Holders: 35

Archer Aviation Inc. (NYSE:ACHR) is one of the best multibagger stocks to invest in right now. With returns already exceeding 150% in the last year, the company is often cited as a potential multibagger in the emerging urban air mobility market. The company is developing eVTOL (electric vertical takeoff and landing) aircraft designed for urban air taxi services.

Six of its flagship Midnight aircraft are in production, with three currently in final assembly. Archer raised $850 million in funding in Q2 2025, bringing its cash reserves to a solid $1.7 billion.

On August 27, short seller Grizzly Research released a report on Archer Aviation Inc. (NYSE:ACHR), drawing parallels to other troubled start-ups and questioning the credibility of its $6 billion order book, the design of its Midnight aircraft, and the pace of production ramp-up at its Georgia facility. The note also raised doubts about the durability of some order commitments and highlighted concerns around recent marketing demonstrations.

Archer Aviation Inc. (NYSE:ACHR) has not yet commented, and Wall Street analysts have not released updated views, while the stock showed little immediate reaction.

Earlier, on August 13, Canaccord Genuity’s Austin Moeller maintained a Buy rating with a $13 price target after Q2 results. While acknowledging a sizable adjusted EBITDA loss, Moeller pointed to progress in scaling Midnight aircraft production across California and Georgia, and highlighted Archer Aviation Inc.’s (NYSE:ACHR) strengthened balance sheet following the capital raise. He also noted the company’s advancement in FAA certification, where it is among a select group in the final phase, as a critical step toward commercialization.

These differing perspectives underline the debate surrounding Archer Aviation Inc. (NYSE:ACHR). The short-seller’s report highlights questions around execution and order strength, while analyst views point to Archer’s funding base, progress with certification, and potential growth ahead. There could be volatility in the near term, but with substantial upside if the company is able to deliver on its key operational goals.

Archer Aviation Inc. (NYSE:ACHR) is a U.S.-based aerospace company developing electric vertical take-off and landing (eVTOL) aircraft for urban air mobility.